Connect with us

Stocks Setting Up for Big Moves Next Week!

Over the past couple of weeks, over 50% of the companies in the S&P 500 have reported results for Q2 2021. Of those, 88% have reported EPS results above estimates. This is well above the average over the past five years.The markets are all about futur

Published

on

Over the past couple of weeks, over 50% of the companies in the S&P 500 have reported results for Q2 2021. Of those, 88% have reported EPS results above estimates. This is well above the average over the past five years.

The markets are all about future growth, however, and the good news is analysts are upgrading their EPS estimates for Q3 by an average of 3.6%. This marks the third largest increase in EPS estimates during the first month of a quarter in eleven years. (source: Factset Research)

Even better news, many of those companies that reported strong 2nd quarter earnings and also had their estimates revised higher are posting huge gains. Each of the top performers from the S&P 500 last week was a company that came in ahead of estimates and had their outlooks upgraded.

Below are four of many examples, and their average gain for the week was 11% -- well above the S&P 500's generally flat performance.

TOP PERFORMERS IN S&P 500 LAST WEEK

It's not too late to capitalize on this market action, as there are plenty more corporations due to report their 2nd quarter results. Below are two companies due next week. They're in industry groups where peer companies have seen explosive moves following strong results, as they provide products that are in high demand.

First up is Small Cap Semiconductor stock Rambus (RBMS), which provides chip design products for the computing, gaming and graphics market. Analysts are anticipating 2nd quarter earnings to grow 875% vs. last year as demand for their products has grown substantially.

RBMS is in the same industry as much larger Applied Micro (AMD), which is listed among the outperformers above. In addition to bullishly receiving a price target upgrade last week, Rambus is a hair away from a 1-month base breakout at $24. The company is due to report earnings after the market's close on Monday.

DAILY CHART OF RAMBUS, INC. (RMBS)

Next up is Western footwear and apparel retailer Boot Barn (BOOT) which is due to report earnings after the market closes on Wednesday. The average estimate is calling for $1.16 in earnings per share, which would be well above last year's negative report due to the pandemic.

BOOT also received a price target upgrade last week ahead of their report, and the stock is in the strong Footwear group, where several peer names such as Crocs (CROX) have gapped up to new highs after coming in ahead of estimates, with analysts raising estimates going forward.

DAILY CHART OF BOOT BARN HOLDINGS, INC. (BOOT)

When searching for additional stock candidates that may far outpace the markets following the release of their 2nd quarter results, here are some key attributes that will improve your success:

First, you'll want the stock to be part of an Industry Group that's seen a number of companies beat estimates and guide higher. This means you're in an area that is experiencing high product demand.

Subscribers to my MEM Edge Report were introduced to West Pharmaceutical (WST) in late April, as it was breaking out of a lengthy base following strong 1st quarter results. The stock is among the top performers (above) as, last week, it gained 9% following another strong quarter. The Medical Supply company provides inject-able drug delivery products which have seen increased demand as vaccine rollouts continue globally.

Another attribute is an analysts' upgrade within 2 weeks of the earnings release. Wall Street analysts are not going to put their neck on the line unless they have some researched insight that have them positive. With Advanced Micro (AMD) listed above, Citigroup finally turned bullish on the stock 2 weeks prior to the company's earnings.

Lastly, a bullish chart is always going to provide an advantage. You'll want the stock to be trading above key support and in an uptrend. While many Bank stocks have been reporting very strong quarterly results, their current downtrends are holding them back from trading higher on the news.

Of course, you'll need the broader markets to remain positive for the above strategy to work. Subscribe to my bi-weekly MEM Edge Report to remain on top of the broader markets, while also being alerted to stocks poised to outperform the broader markets. Use this link here for a special 4-week trial offer!

Warmly,

Mary Ellen McGonagle, MEM Investment Research


In this week's edition of StockCharts TV's The MEM Edge, I review last week's market dynamics and uncover what's supporting the continued uptrend in the broader markets. I also share how to capitalize on the strength in 2nd Quarter GDP. Watch now!

Read More

Continue Reading

Uncategorized

Aging at AACR Annual Meeting 2024

BUFFALO, NY- March 11, 2024 – Impact Journals publishes scholarly journals in the biomedical sciences with a focus on all areas of cancer and aging…

Published

on

BUFFALO, NY- March 11, 2024 – Impact Journals publishes scholarly journals in the biomedical sciences with a focus on all areas of cancer and aging research. Aging is one of the most prominent journals published by Impact Journals

Credit: Impact Journals

BUFFALO, NY- March 11, 2024 – Impact Journals publishes scholarly journals in the biomedical sciences with a focus on all areas of cancer and aging research. Aging is one of the most prominent journals published by Impact Journals

Impact Journals will be participating as an exhibitor at the American Association for Cancer Research (AACR) Annual Meeting 2024 from April 5-10 at the San Diego Convention Center in San Diego, California. This year, the AACR meeting theme is “Inspiring Science • Fueling Progress • Revolutionizing Care.”

Visit booth #4159 at the AACR Annual Meeting 2024 to connect with members of the Aging team.

About Aging-US:

Aging publishes research papers in all fields of aging research including but not limited, aging from yeast to mammals, cellular senescence, age-related diseases such as cancer and Alzheimer’s diseases and their prevention and treatment, anti-aging strategies and drug development and especially the role of signal transduction pathways such as mTOR in aging and potential approaches to modulate these signaling pathways to extend lifespan. The journal aims to promote treatment of age-related diseases by slowing down aging, validation of anti-aging drugs by treating age-related diseases, prevention of cancer by inhibiting aging. Cancer and COVID-19 are age-related diseases.

Aging is indexed and archived by PubMed/Medline (abbreviated as “Aging (Albany NY)”), PubMed CentralWeb of Science: Science Citation Index Expanded (abbreviated as “Aging‐US” and listed in the Cell Biology and Geriatrics & Gerontology categories), Scopus (abbreviated as “Aging” and listed in the Cell Biology and Aging categories), Biological Abstracts, BIOSIS Previews, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

Please visit our website at www.Aging-US.com​​ and connect with us:

  • Aging X
  • Aging Facebook
  • Aging Instagram
  • Aging YouTube
  • Aging LinkedIn
  • Aging SoundCloud
  • Aging Pinterest
  • Aging Reddit

Click here to subscribe to Aging publication updates.

For media inquiries, please contact media@impactjournals.com.


Read More

Continue Reading

Government

Mathematicians use AI to identify emerging COVID-19 variants

Scientists at The Universities of Manchester and Oxford have developed an AI framework that can identify and track new and concerning COVID-19 variants…

Published

on

Scientists at The Universities of Manchester and Oxford have developed an AI framework that can identify and track new and concerning COVID-19 variants and could help with other infections in the future.

Credit: source: https://phil.cdc.gov/Details.aspx?pid=23312

Scientists at The Universities of Manchester and Oxford have developed an AI framework that can identify and track new and concerning COVID-19 variants and could help with other infections in the future.

The framework combines dimension reduction techniques and a new explainable clustering algorithm called CLASSIX, developed by mathematicians at The University of Manchester. This enables the quick identification of groups of viral genomes that might present a risk in the future from huge volumes of data.

The study, presented this week in the journal PNAS, could support traditional methods of tracking viral evolution, such as phylogenetic analysis, which currently require extensive manual curation.

Roberto Cahuantzi, a researcher at The University of Manchester and first and corresponding author of the paper, said: “Since the emergence of COVID-19, we have seen multiple waves of new variants, heightened transmissibility, evasion of immune responses, and increased severity of illness.

“Scientists are now intensifying efforts to pinpoint these worrying new variants, such as alpha, delta and omicron, at the earliest stages of their emergence. If we can find a way to do this quickly and efficiently, it will enable us to be more proactive in our response, such as tailored vaccine development and may even enable us to eliminate the variants before they become established.”

Like many other RNA viruses, COVID-19 has a high mutation rate and short time between generations meaning it evolves extremely rapidly. This means identifying new strains that are likely to be problematic in the future requires considerable effort.

Currently, there are almost 16 million sequences available on the GISAID database (the Global Initiative on Sharing All Influenza Data), which provides access to genomic data of influenza viruses.

Mapping the evolution and history of all COVID-19 genomes from this data is currently done using extremely large amounts of computer and human time.

The described method allows automation of such tasks. The researchers processed 5.7 million high-coverage sequences in only one to two days on a standard modern laptop; this would not be possible for existing methods, putting identification of concerning pathogen strains in the hands of more researchers due to reduced resource needs.

Thomas House, Professor of Mathematical Sciences at The University of Manchester, said: “The unprecedented amount of genetic data generated during the pandemic demands improvements to our methods to analyse it thoroughly. The data is continuing to grow rapidly but without showing a benefit to curating this data, there is a risk that it will be removed or deleted.

“We know that human expert time is limited, so our approach should not replace the work of humans all together but work alongside them to enable the job to be done much quicker and free our experts for other vital developments.”

The proposed method works by breaking down genetic sequences of the COVID-19 virus into smaller “words” (called 3-mers) represented as numbers by counting them. Then, it groups similar sequences together based on their word patterns using machine learning techniques.

Stefan Güttel, Professor of Applied Mathematics at the University of Manchester, said: “The clustering algorithm CLASSIX we developed is much less computationally demanding than traditional methods and is fully explainable, meaning that it provides textual and visual explanations of the computed clusters.”

Roberto Cahuantzi added: “Our analysis serves as a proof of concept, demonstrating the potential use of machine learning methods as an alert tool for the early discovery of emerging major variants without relying on the need to generate phylogenies.

“Whilst phylogenetics remains the ‘gold standard’ for understanding the viral ancestry, these machine learning methods can accommodate several orders of magnitude more sequences than the current phylogenetic methods and at a low computational cost.”


Read More

Continue Reading

International

There will soon be one million seats on this popular Amtrak route

“More people are taking the train than ever before,” says Amtrak’s Executive Vice President.

Published

on

While the size of the United States makes it hard for it to compete with the inter-city train access available in places like Japan and many European countries, Amtrak trains are a very popular transportation option in certain pockets of the country — so much so that the country’s national railway company is expanding its Northeast Corridor by more than one million seats.

Related: This is what it's like to take a 19-hour train from New York to Chicago

Running from Boston all the way south to Washington, D.C., the route is one of the most popular as it passes through the most densely populated part of the country and serves as a commuter train for those who need to go between East Coast cities such as New York and Philadelphia for business.

Veronika Bondarenko captured this photo of New York’s Moynihan Train Hall. 

Veronika Bondarenko

Amtrak launches new routes, promises travelers ‘additional travel options’

Earlier this month, Amtrak announced that it was adding four additional Northeastern routes to its schedule — two more routes between New York’s Penn Station and Union Station in Washington, D.C. on the weekend, a new early-morning weekday route between New York and Philadelphia’s William H. Gray III 30th Street Station and a weekend route between Philadelphia and Boston’s South Station.

More Travel:

According to Amtrak, these additions will increase Northeast Corridor’s service by 20% on the weekdays and 10% on the weekends for a total of one million additional seats when counted by how many will ride the corridor over the year.

“More people are taking the train than ever before and we’re proud to offer our customers additional travel options when they ride with us on the Northeast Regional,” Amtrak Executive Vice President and Chief Commercial Officer Eliot Hamlisch said in a statement on the new routes. “The Northeast Regional gets you where you want to go comfortably, conveniently and sustainably as you breeze past traffic on I-95 for a more enjoyable travel experience.”

Here are some of the other Amtrak changes you can expect to see

Amtrak also said that, in the 2023 financial year, the Northeast Corridor had nearly 9.2 million riders — 8% more than it had pre-pandemic and a 29% increase from 2022. The higher demand, particularly during both off-peak hours and the time when many business travelers use to get to work, is pushing Amtrak to invest into this corridor in particular.

To reach more customers, Amtrak has also made several changes to both its routes and pricing system. In the fall of 2023, it introduced a type of new “Night Owl Fare” — if traveling during very late or very early hours, one can go between cities like New York and Philadelphia or Philadelphia and Washington. D.C. for $5 to $15.

As travel on the same routes during peak hours can reach as much as $300, this was a deliberate move to reach those who have the flexibility of time and might have otherwise preferred more affordable methods of transportation such as the bus. After seeing strong uptake, Amtrak added this type of fare to more Boston routes.

The largest distances, such as the ones between Boston and New York or New York and Washington, are available at the lowest rate for $20.

Read More

Continue Reading

Trending